report cover

Natural Killer Cell Therapy Market, Global Outlook and Forecast 2023-2029

  • 30 March 2023
  • Life Sciences
  • 69 Pages
  • Report code : 24WT-7621689

Natural Killer Cell Therapy and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Natural Killer Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer Cell Therapy Overall Market Size
2.1 Global Natural Killer Cell Therapy Market Size: 2022 VS 2029
2.2 Global Natural Killer Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer Cell Therapy Players in Global Market
3.2 Top Global Natural Killer Cell Therapy Companies Ranked by Revenue
3.3 Global Natural Killer Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Natural Killer Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Natural Killer Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global Natural Killer Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Natural Killer Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Natural Killer Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer Cell Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Gastrointestinal Diseases
5.1.4 Others
5.2 By Application - Global Natural Killer Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Natural Killer Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Natural Killer Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Natural Killer Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global Natural Killer Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Natural Killer Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Natural Killer Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Natural Killer Cell Therapy Revenue, 2018-2029
6.3.2 US Natural Killer Cell Therapy Market Size, 2018-2029
6.3.3 Canada Natural Killer Cell Therapy Market Size, 2018-2029
6.3.4 Mexico Natural Killer Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Natural Killer Cell Therapy Revenue, 2018-2029
6.4.2 Germany Natural Killer Cell Therapy Market Size, 2018-2029
6.4.3 France Natural Killer Cell Therapy Market Size, 2018-2029
6.4.4 U.K. Natural Killer Cell Therapy Market Size, 2018-2029
6.4.5 Italy Natural Killer Cell Therapy Market Size, 2018-2029
6.4.6 Russia Natural Killer Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Natural Killer Cell Therapy Market Size, 2018-2029
6.4.8 Benelux Natural Killer Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Natural Killer Cell Therapy Revenue, 2018-2029
6.5.2 China Natural Killer Cell Therapy Market Size, 2018-2029
6.5.3 Japan Natural Killer Cell Therapy Market Size, 2018-2029
6.5.4 South Korea Natural Killer Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Natural Killer Cell Therapy Market Size, 2018-2029
6.5.6 India Natural Killer Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Natural Killer Cell Therapy Revenue, 2018-2029
6.6.2 Brazil Natural Killer Cell Therapy Market Size, 2018-2029
6.6.3 Argentina Natural Killer Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer Cell Therapy Revenue, 2018-2029
6.7.2 Turkey Natural Killer Cell Therapy Market Size, 2018-2029
6.7.3 Israel Natural Killer Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Natural Killer Cell Therapy Market Size, 2018-2029
6.7.5 UAE Natural Killer Cell Therapy Market Size, 2018-2029
7 Natural Killer Cell Therapy Companies Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Company Summary
7.1.2 Nektar Therapeutics Business Overview
7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Nektar Therapeutics Key News & Latest Developments
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Company Summary
7.2.2 Innate Pharma SA Business Overview
7.2.3 Innate Pharma SA Natural Killer Cell Therapy Major Product Offerings
7.2.4 Innate Pharma SA Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Innate Pharma SA Key News & Latest Developments
7.3 Affimed
7.3.1 Affimed Company Summary
7.3.2 Affimed Business Overview
7.3.3 Affimed Natural Killer Cell Therapy Major Product Offerings
7.3.4 Affimed Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Affimed Key News & Latest Developments
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Company Summary
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Major Product Offerings
7.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Chipscreen Biosciences Key News & Latest Developments
7.5 Glycostem Therapeutics
7.5.1 Glycostem Therapeutics Company Summary
7.5.2 Glycostem Therapeutics Business Overview
7.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Glycostem Therapeutics Key News & Latest Developments
7.6 Fate Therapeutics
7.6.1 Fate Therapeutics Company Summary
7.6.2 Fate Therapeutics Business Overview
7.6.3 Fate Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Fate Therapeutics Key News & Latest Developments
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Company Summary
7.7.2 Dragonfly Therapeutics Business Overview
7.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Dragonfly Therapeutics Key News & Latest Developments
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Company Summary
7.8.2 Kiadis Pharma Business Overview
7.8.3 Kiadis Pharma Natural Killer Cell Therapy Major Product Offerings
7.8.4 Kiadis Pharma Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Kiadis Pharma Key News & Latest Developments
7.9 Nkarta Therapeutics
7.9.1 Nkarta Therapeutics Company Summary
7.9.2 Nkarta Therapeutics Business Overview
7.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Nkarta Therapeutics Key News & Latest Developments
7.10 NantKwest
7.10.1 NantKwest Company Summary
7.10.2 NantKwest Business Overview
7.10.3 NantKwest Natural Killer Cell Therapy Major Product Offerings
7.10.4 NantKwest Natural Killer Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 NantKwest Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Natural Killer Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Natural Killer Cell Therapy Market Drivers in Global Market
Table 3. Natural Killer Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Natural Killer Cell Therapy in Global Market
Table 5. Top Natural Killer Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Natural Killer Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Natural Killer Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Natural Killer Cell Therapy Product Type
Table 9. List of Global Tier 1 Natural Killer Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natural Killer Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Natural Killer Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Natural Killer Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Natural Killer Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Natural Killer Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Natural Killer Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Natural Killer Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Natural Killer Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Nektar Therapeutics Company Summary
Table 31. Nektar Therapeutics Natural Killer Cell Therapy Product Offerings
Table 32. Nektar Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Nektar Therapeutics Key News & Latest Developments
Table 34. Innate Pharma SA Company Summary
Table 35. Innate Pharma SA Natural Killer Cell Therapy Product Offerings
Table 36. Innate Pharma SA Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Innate Pharma SA Key News & Latest Developments
Table 38. Affimed Company Summary
Table 39. Affimed Natural Killer Cell Therapy Product Offerings
Table 40. Affimed Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Affimed Key News & Latest Developments
Table 42. Chipscreen Biosciences Company Summary
Table 43. Chipscreen Biosciences Natural Killer Cell Therapy Product Offerings
Table 44. Chipscreen Biosciences Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Chipscreen Biosciences Key News & Latest Developments
Table 46. Glycostem Therapeutics Company Summary
Table 47. Glycostem Therapeutics Natural Killer Cell Therapy Product Offerings
Table 48. Glycostem Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Glycostem Therapeutics Key News & Latest Developments
Table 50. Fate Therapeutics Company Summary
Table 51. Fate Therapeutics Natural Killer Cell Therapy Product Offerings
Table 52. Fate Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Fate Therapeutics Key News & Latest Developments
Table 54. Dragonfly Therapeutics Company Summary
Table 55. Dragonfly Therapeutics Natural Killer Cell Therapy Product Offerings
Table 56. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Dragonfly Therapeutics Key News & Latest Developments
Table 58. Kiadis Pharma Company Summary
Table 59. Kiadis Pharma Natural Killer Cell Therapy Product Offerings
Table 60. Kiadis Pharma Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Kiadis Pharma Key News & Latest Developments
Table 62. Nkarta Therapeutics Company Summary
Table 63. Nkarta Therapeutics Natural Killer Cell Therapy Product Offerings
Table 64. Nkarta Therapeutics Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Nkarta Therapeutics Key News & Latest Developments
Table 66. NantKwest Company Summary
Table 67. NantKwest Natural Killer Cell Therapy Product Offerings
Table 68. NantKwest Natural Killer Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. NantKwest Key News & Latest Developments
List of Figures
Figure 1. Natural Killer Cell Therapy Segment by Type in 2022
Figure 2. Natural Killer Cell Therapy Segment by Application in 2022
Figure 3. Global Natural Killer Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Natural Killer Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Natural Killer Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2022
Figure 8. By Type - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Natural Killer Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Natural Killer Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Natural Killer Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Nektar Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Innate Pharma SA Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Affimed Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Chipscreen Biosciences Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Glycostem Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Fate Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kiadis Pharma Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nkarta Therapeutics Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. NantKwest Natural Killer Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Natural Killer Cell Therapy and Forecast Market

Leave This Empty: